Figure1.jpg (Figure1)
Cilostazol Tablet
Product Images NDC 60505-2521
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cilostazol (NDC 60505-2521). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure2.jpg (Figure2)
Structure.jpg (Structure)
Cilo-imtb-100mg-lbl-60 (Cilo Imtb 100mg Lbl 60)
This is a medication label for Giostazol 100 mg tablets, which come in a bottle of 60 tablets. The tablets should be stored between 15°C to 25°C (59°F to 77°F). The usual dosage is one tablet taken twice daily. The package insert has more information about prescription details. The drug is manufactured by Apotex Corp. The label includes a National Drug Code (NDC) number for identification purposes. The pharmacist is instructed to provide patients with an enclosed Patient Information Leaflet.*
Cilo-imtb-50mg-lbl-60 (Cilo Imtb 50mg Lbl 60)
This is a medication label for Cilostazol 50 mg tablets. It advises to store the medication at a temperature range of 15°C to 25°C. The recommended dosage is two tablets. The label also includes a product code, dosage form, and the name of the manufacturer. It suggests referring to the package insert for complete prescribing information and provides a National Drug Code (NDC) number for the tablets. Additionally, it warns the pharmacist to dispense the enclosed patient information leaflet to each patient.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
